175 related articles for article (PubMed ID: 7876371)
1. Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia.
Hutchesson AC; Moran A; Jones AF
J Clin Pharm Ther; 1994 Dec; 19(6):387-9. PubMed ID: 7876371
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins.
Nakandakare E; Garcia RC; Rocha JC; Sperotto G; Oliveira HC; Quintão EC
Atherosclerosis; 1990 Dec; 85(2-3):211-7. PubMed ID: 2102085
[TBL] [Abstract][Full Text] [Related]
3. The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.
Stewart MW; Dyer RG; Alberti KG; Laker MF
Diabet Med; 1995 Mar; 12(3):250-7. PubMed ID: 7758262
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM.
Jeck T; Riesen WF; Keller U
Diabet Med; 1997 Jul; 14(7):564-70. PubMed ID: 9223394
[TBL] [Abstract][Full Text] [Related]
5. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.
Kehely A; MacMahon M; Barbir M; Wray R; Hunt BJ; Prescott RJ; Thompson GR
QJM; 1995 Jun; 88(6):421-7. PubMed ID: 7648234
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
Bruckert E; De Gennes JL; Malbecq W; Baigts F
Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
[TBL] [Abstract][Full Text] [Related]
7. Normocholesterolaemic dysslipidaemia: is there a role for fibrates?
Hamilton-Craig I
Med J Aust; 2001 Jun; 174(11):610; author reply 611. PubMed ID: 11453341
[No Abstract] [Full Text] [Related]
8. The effect of simvastatin and bezafibrate on bile composition and gall-bladder emptying in female non-insulin-dependent diabetics.
Wilson IR; Hurrell MA; Pattinson NR; Chapman BA
J Gastroenterol Hepatol; 1994; 9(5):447-51. PubMed ID: 7827294
[TBL] [Abstract][Full Text] [Related]
9. Effects of bezafibrate and simvastatin on plasma lipoproteins in hypercholesterolemia resistant to hormone replacement therapy.
Ohmichi M; Ikegami H; Kurachi H; Node K; Morishige K; Nishio Y; Adachi K; Matumoto K; Hayakawa J; Tasaka K; Azuma C; Murata Y
Maturitas; 2001 May; 38(3):279-86. PubMed ID: 11358645
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with type 2 diabetes mellitus.
Rustemeijer C; Schouten JA; Voerman HJ; Hensgens HE; Donker AJ; Heine RJ
Diabetes Metab Res Rev; 2000; 16(2):82-7. PubMed ID: 10751747
[TBL] [Abstract][Full Text] [Related]
11. Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits.
Hidalgo L; López-Miranda J; Espino A; Alcala J; Blanco J; Prada JL; Rodríguez M; Jiménez-Perepérez JA; Jansen S; Pérez-Jiménez F
Transplant Proc; 1995 Apr; 27(2):1857-61. PubMed ID: 7725532
[No Abstract] [Full Text] [Related]
12. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia.
Smith DH; Neutel JM; Jankelow D; Myburgh DP
S Afr Med J; 1990 May; 77(10):500-3. PubMed ID: 2188379
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study).
Pauciullo P; Borgnino C; Paoletti R; Mariani M; Mancini M
Atherosclerosis; 2000 Jun; 150(2):429-36. PubMed ID: 10856536
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation.
Hidalgo L; Zambrana JL; Blanco-Molina A; López-Granados A; Concha M; Casares J; Jiménez-Pérez J; López-Miranda J; Pérez-Jiménez F
J Heart Lung Transplant; 1995; 14(3):461-7. PubMed ID: 7654731
[TBL] [Abstract][Full Text] [Related]
15. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
17. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR
Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811
[TBL] [Abstract][Full Text] [Related]
18. A case for lipid-lowering?
Durrington P
Diabet Med; 2000 Sep; 17 Suppl 2():4-5. PubMed ID: 11048824
[No Abstract] [Full Text] [Related]
19. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Didangelos TP; Carina MV; Kranitsas DF; Kontopoulos AG
Am J Cardiol; 1997 Sep; 80(5):608-13. PubMed ID: 9294990
[TBL] [Abstract][Full Text] [Related]
20. Implications of 4S evidence on baseline lipid levels.
Durrington PN
Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
[No Abstract] [Full Text] [Related]
[Next] [New Search]